Literature DB >> 1386607

An unusual splicing mutation in the HEXB gene is associated with dramatically different phenotypes in patients from different racial backgrounds.

B McInnes1, M Potier, N Wakamatsu, S B Melancon, M H Klavins, S Tsuji, D J Mahuran.   

Abstract

Sandhoff disease is caused by mutations affecting the beta subunit of lysosomal beta-hexosaminidase (EC 3.2.1.52) and displays a wide spectrum of clinical phenotypes. We report a 57-year-old patient with a very mild phenotype, although residual hexosaminidase A activity in his cultured fibroblasts was less than 3% of normal activity, a level observed in juvenile onset patients. Northern and Western blot analyses confirmed a similar low level of beta subunit-mRNA and mature beta-protein, respectively. Two mutations of the HEXB gene were identified in this patient, a partial 5' gene deletion (a null allele), and a C----T transition 8 nucleotides downstream from the intron 10/exon 11 junction affecting the splicing of the beta subunit-mRNA. In their homozygous forms, the 5' deletion has been previously shown to result in a severe infantile phenotype, and the C----T transition in a juvenile phenotype. The genotype and the low level of residual hexosaminidase A activity would be expected to produce a juvenile Sandhoff phenotype in this patient, as well as in four of his six clinically normal siblings. The biochemical basis of his mild phenotype is uncertain, but may result from genetic variations in the RNA splicing machinery.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386607      PMCID: PMC443103          DOI: 10.1172/JCI115863

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Genetic cause of a juvenile form of Sandhoff disease. Abnormal splicing of beta-hexosaminidase beta chain gene transcript due to a point mutation within intron 12.

Authors:  T Nakano; K Suzuki
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

Review 2.  Lysosomal storage diseases.

Authors:  E F Neufeld
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

Review 3.  Alternative splicing in the control of gene expression.

Authors:  C W Smith; J G Patton; B Nadal-Ginard
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

4.  Proteolytic processing of pro-alpha and pro-beta precursors from human beta-hexosaminidase. Generation of the mature alpha and beta a beta b subunits.

Authors:  D J Mahuran; K Neote; M H Klavins; A Leung; R A Gravel
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

5.  Automated assay of hexosaminidases in serum.

Authors:  J A Lowden; M A Skomorowski; F Henderson; M Kaback
Journal:  Clin Chem       Date:  1973-12       Impact factor: 8.327

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Tay-Sachs disease: heterozygote screening and prenatal diagnosis--U.S. experience and world perspective.

Authors:  M M Kaback; T J Nathan; S Greenwald
Journal:  Prog Clin Biol Res       Date:  1977

8.  Isolation and expression in Escherichia coli of a cDNA clone encoding human beta-glucuronidase.

Authors:  K S Guise; R G Korneluk; J Waye; A M Lamhonwah; F Quan; R Palmer; R E Ganschow; W S Sly; R A Gravel
Journal:  Gene       Date:  1985       Impact factor: 3.688

9.  Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2.

Authors:  A Hasilik; K von Figura; E Conzelmann; H Nehrkorn; K Sandhoff
Journal:  Eur J Biochem       Date:  1982-07

10.  Adult onset motor neuronopathy in the juvenile type of hexosaminidase A and B deficiency.

Authors:  M Rubin; G Karpati; L S Wolfe; S Carpenter; M H Klavins; D J Mahuran
Journal:  J Neurol Sci       Date:  1988-10       Impact factor: 3.181

View more
  14 in total

1.  Characterization of the mutant β-subunit of β-hexosaminidase for dimer formation responsible for the adult form of Sandhoff disease with the motor neuron disease phenotype.

Authors:  Kenichiro Yamada; Yuhei Takado; Yusuke S Kato; Yasukazu Yamada; Hideaki Ishiguro; Nobuaki Wakamatsu
Journal:  J Biochem       Date:  2012-11-05       Impact factor: 3.387

Review 2.  The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

Authors:  Gustavo H B Maegawa; Tracy Stockley; Michael Tropak; Brenda Banwell; Susan Blaser; Fernando Kok; Roberto Giugliani; Don Mahuran; Joe T R Clarke
Journal:  Pediatrics       Date:  2006-10-02       Impact factor: 7.124

3.  A common beta hexosaminidase gene mutation in adult Sandhoff disease patients.

Authors:  M Gomez-Lira; A Sangalli; M Mottes; C Perusi; P F Pignatti; N Rizzuto; A Salviati
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

4.  Single exon mutation in arylsulfatase A gene has two effects: loss of enzyme activity and aberrant splicing.

Authors:  Y Hasegawa; H Kawame; H Ida; T Ohashi; Y Eto
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

Review 5.  Pathology and current treatment of neurodegenerative sphingolipidoses.

Authors:  Matthias Eckhardt
Journal:  Neuromolecular Med       Date:  2010-08-22       Impact factor: 3.843

6.  The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.

Authors:  N Rave-Harel; E Kerem; M Nissim-Rafinia; I Madjar; R Goshen; A Augarten; A Rahat; A Hurwitz; A Darvasi; B Kerem
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

7.  Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.

Authors:  F X Arredondo-Vega; I Santisteban; S Kelly; C M Schlossman; D T Umetsu; M S Hershfield
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

8.  Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidase.

Authors:  Tyler Mark Pierson; Paola A Torres; Bei-Jin Zeng; Allan M Glanzman; David Adams; Richard S Finkel; Don J Mahuran; Gregory M Pastores; Gihan I Tennekoon; Edwin H Kolodny
Journal:  Mol Genet Metab       Date:  2012-11-02       Impact factor: 4.797

9.  Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.

Authors:  I Santisteban; F X Arredondo-Vega; S Kelly; A Mary; A Fischer; D S Hummell; A Lawton; R U Sorensen; E R Stiehm; L Uribe
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Sandhoff disease in Argentina: high frequency of a splice site mutation in the HEXB gene and correlation between enzyme and DNA-based tests for heterozygote detection.

Authors:  F E Kleiman; R D de Kremer; A O de Ramirez; R A Gravel; C E Argaraña
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.